Profile | GDS2987 / GI_8922949-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 37.8 | 67 |
GSM215244 | HMVEC_vehicle_rep2 | 67.6 | 72 |
GSM215253 | HMVEC_vehicle_rep3 | 81.9 | 75 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | 5 | 12 |
GSM215344 | HMVEC_atorvastatin_rep2 | ||
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 13.7 | 27 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 13.8 | 27 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 22 | 58 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 32 | 45 |
GSM215310 | PASMC_vehicle_rep3 | 7.6 | 12 |
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | 3.7 | 6 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 19.6 | 32 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 28.8 | 48 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 3.7 | 6 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | 2.5 | 5 |
GSM215330 | Fibroblasts_vehicle_rep1 | 161.3 | 80 |
GSM215331 | Fibroblasts_vehicle_rep2 | 241.5 | 83 |
GSM215332 | Fibroblasts_vehicle_rep3 | 196.9 | 82 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 141.8 | 79 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 178.6 | 80 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 163.5 | 79 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 228 | 83 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 196.9 | 82 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 184 | 81 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 155.6 | 79 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 147.4 | 79 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 130.2 | 77 |